Trial of EDG-5506, Becker MD Treatment, Begins Enrolling Patients | Oral Therapy Aims to Preserve Muscle Health
A Phase 2 scientific demo testing Edgewise Therapeutics’ investigational oral therapy EDG-5506 is recruiting boys and adult males with Becker muscular dystrophy (BMD). Identified as CANYON (NCT05291091), the review plans to enroll up to 66 BMD people, ages 12–50, throughout 14 medical web pages in the U.S., U.K., and the Netherlands. Recruitment is at this time open up at the College of Massachusetts’ website make contact with and locale facts to day is readily available. “We are delighted to advance EDG-5506…